Serum Institute of India acquires 20% stake in IntegriMedical

The largest vaccine manufacturer in the world, Serum Institute of India (SII), purchased a 20% share in IntegriMedical, a US-based company, in order to further the development of needle-free injection system technology.

The deal’s financial specifics were kept under wraps.

In a statement released on Friday, Pune-based SII said that the collaboration with IntegriMedical is in line with both company’s goals of “Health for All” and “Transforming Healthcare Globally” through the provision of patient comfort, assurance of improved patient compliance, a decrease in needle-stick injuries, and an improvement in the effectiveness of liquid medication through needle-free dispersion.

Read more@ https://www.indiainfoline.com/news/companies/serum-institute-acquires-20-stake-in-integrimedical


Comments

Popular posts from this blog

Intramuscular Injections

Intramuscular Injections: The Future of Pain-Free Vaccinations

Subcutaneous Injections